148 related articles for article (PubMed ID: 4934281)
1. Cancer in the immunosuppressed patient.
Fahey JL
Ann Intern Med; 1971 Aug; 75(2):310-2. PubMed ID: 4934281
[No Abstract] [Full Text] [Related]
2. [Cancer and immunosuppressive treatment. Apropos of 2 cases].
Le Goff P; Le Menn G
Sem Hop; 1974 Feb; 50(10):657-63. PubMed ID: 4366161
[No Abstract] [Full Text] [Related]
3. The occurrence of malignant tumors in immunosuppressed states.
Penn I
Prog Allergy; 1986; 37():259-300. PubMed ID: 3515352
[No Abstract] [Full Text] [Related]
4. Skin tumours in immunosuppressed patients.
Marshall VC
Aust N Z J Surg; 1973 Dec; 43(3):214-22. PubMed ID: 4618104
[No Abstract] [Full Text] [Related]
5. Colposcopic and cytologic evaluation of women undergoing immunosuppressive therapy.
Donohue LR
J Reprod Med; 1974 May; 12(5):194-6. PubMed ID: 4599291
[No Abstract] [Full Text] [Related]
6. Cancer is a complication of severe immunosuppression.
Penn I
Surg Gynecol Obstet; 1986 Jun; 162(6):603-10. PubMed ID: 3520906
[TBL] [Abstract][Full Text] [Related]
7. Primary malignancy in patients undergoing immunosuppression for renal transplantation.
McKhann CF
Transplantation; 1969 Aug; 8(2):209-12. PubMed ID: 4896335
[No Abstract] [Full Text] [Related]
8. Cancers after cyclosporine therapy.
Penn I; Brunson ME
Transplant Proc; 1988 Jun; 20(3 Suppl 3):885-92. PubMed ID: 3388524
[No Abstract] [Full Text] [Related]
9. The role of immunosuppression in the genesis and growth of malignant tumours.
Reis HE
Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
[No Abstract] [Full Text] [Related]
10. Analysis of the immunosuppressive and oncogenic effects of heterologous antilymphocyte serum.
Zipp P; Kountz SL
Am J Surg; 1971 Aug; 122(2):204-8. PubMed ID: 4934807
[No Abstract] [Full Text] [Related]
11. Leukaemia and cancer in relation to immunosuppressive therapy.
Videbaek A
Scand J Haematol; 1973; 10(4):241-3. PubMed ID: 4587559
[No Abstract] [Full Text] [Related]
12. Iatrogenic immunosuppression and cutaneous malignancy.
DePry JL; Reed KB; Cook-Norris RH; Brewer JD
Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
Kinlen LJ
Am J Med; 1985 Jan; 78(1A):44-9. PubMed ID: 3970040
[TBL] [Abstract][Full Text] [Related]
14. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
Molin L; Larkö O
Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
[No Abstract] [Full Text] [Related]
15. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
Ehlers G
Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
[No Abstract] [Full Text] [Related]
16. Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancer.
Assassi S
BMJ; 2016 Jan; 352():i472. PubMed ID: 26822198
[No Abstract] [Full Text] [Related]
17. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
18. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
19. Malignancies associated with immunosuppressive or cytotoxic therapy.
Penn I
Surgery; 1978 May; 83(5):492-502. PubMed ID: 347611
[No Abstract] [Full Text] [Related]
20. [Malignant neoplasms after organ transplantation].
Mol'kov IuN; Golikova SD; Balakirev EM
Vopr Onkol; 1980; 26(11):107-13. PubMed ID: 7006209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
